The coronavirus public health emergency, declared by the Trump administration in 2020, will expire on Thursday. Interviews with senior health officials suggest the nation is not ready for a new pandemic.
While the U.S. has greatly improved its capacity to fight COVID-19, it is not fully prepared for a radically different future variant or a new pandemic.
GSK’s Arexvy, a vaccine against respiratory syncytial virus, was approved by the FDA and is expected to be available this fall for adults aged 60 years and older.It is the world’s first RSV vaccine to receive FDA approval, according to the agency. It was the top story in infectious disease last week.
This Week in Washington: Debt Limit fight continues; Disagreements arise during Senate HELP Committee mark-up of PBM and Generic Drug Competition Bills.